NCT05982405

Brief Summary

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. For this reason, in this study, it was aimed to investigate the long-term results of inspiratory muscle training in individuals with chronic venous insufficiency.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

10 months

First QC Date

July 28, 2023

Last Update Submit

May 16, 2025

Conditions

Keywords

Venous Insufficiencypainedemarespiratory function testsmaximal respiratory pressuresexercise capacityquality of life

Outcome Measures

Primary Outcomes (1)

  • Maximal inspiratory pressure (MIP)

    The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    After 6-week training and 3 months after 6-week training ends.

Secondary Outcomes (10)

  • Maximal expiratory pressure (MEP)

    After 6-week training and 3 months after 6-week training ends.

  • Forced vital capacity (FVC)

    After 6-week training and 3 months after 6-week training ends.

  • Forced expiratory volume in the first second (FEV1)

    After 6-week training and 3 months after 6-week training ends.

  • FEV1 / FVC

    After 6-week training and 3 months after 6-week training ends.

  • Flow rate 25-75% of forced expiratory volume (FEF 25-75%)

    After 6-week training and 3 months after 6-week training ends.

  • +5 more secondary outcomes

Study Arms (2)

Training group

EXPERIMENTAL

The individuals in the training group will be performed inspiratory muscle training using an inspiratory muscle training device (PowerBreathe®) at 30-50% of the maximal inspiratory pressure.

Other: Training group: Inspiratory muscle training

Control group

SHAM COMPARATOR

Individuals in the control group will be performed thoracic expansion exercises.

Other: Control group: Thoracic expansion exercise

Interventions

The individuals in the training group will be performed inspiratory muscle training at 30-50% of the maximal inspiratory pressure. Inspiratory muscle training will be done using an inspiratory muscle training device (PowerBreathe®) that works with the threshold loading principle. Inspiratory muscle training will be done for 15 minutes per a session, 2 times per a day or, if tolerated, 30 minutes per a day and 1 time per a day, 5-7 days/week (one session under the supervision and the others at home), for a total of 6 weeks. Applications made at home will be followed with a diary.

Also known as: Experimental: Training group
Training group

Individuals in the control group will be performed thoracic expansion exercises. Thoracic expansion exercises will be applied to individuals in an upright sitting position. In this position, individuals will place their hands on their lower ribs and then perform the cycle of "deep breathing + holding the deep breath for 3 seconds + slowly emptying all the breath" 3 times in a row. After this cycle, individuals will be asked to rest by taking 3-4 calm breaths. Immediately after, the individual will be asked to repeat the same cycle and repeat the cycle with calm breaths and rest until it reaches 10 repetitions. The individual will do this session 4 times a day. Individuals will do the first session of breathing exercises under supervision. In this way, incorrect exercise will be prevented. Other breathing exercise sessions will be done by individuals as a home program every day and 4 sessions a day during 6 weeks.

Also known as: Sham Comparator: Control group
Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Volunteering to participate in the study
  • Diagnosed with chronic venous insufficiency using duplex ultrasound and being under standard medical treatment follow-up
  • Being in one of the C1, C2, C3, C4 or C5 stages according to the Clinical, Etiology, Anatomy and Pathophysiology (CEAP) classification

You may not qualify if:

  • Acute deep vein thrombosis, active ulcers, psychiatric disorder requiring prior vessel ablation and/or prescription drug therapy,
  • Any history of chronic disease or deep vein thrombosis that may interfere with exercise capacity measurement,
  • Having SARS-CoV-2 (COVID-19) or any acute infection,
  • Being pregnant,
  • History of arterial disease,
  • Having advanced cardiorespiratory diseases, acute ulcer (\< 3 months) and diabetic ulcers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Democracy University

Izmir, 35140, Turkey (Türkiye)

Location

Related Publications (3)

  • Aydin G, Yeldan I, Akgul A, Ipek G. Effects of inspiratory muscle training versus calf muscle training on quality of life, pain, venous function and activity in patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1137-1146. doi: 10.1016/j.jvsv.2022.04.012. Epub 2022 Jun 14.

    PMID: 35710091BACKGROUND
  • Weiss RA, Munavalli G. Endovenous ablation of truncal veins. Semin Cutan Med Surg. 2005 Dec;24(4):193-9. doi: 10.1016/j.sder.2005.10.006.

    PMID: 16387263BACKGROUND
  • Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005 May 10;111(18):2398-409. doi: 10.1161/01.CIR.0000164199.72440.08. No abstract available.

    PMID: 15883226BACKGROUND

MeSH Terms

Conditions

Venous InsufficiencyPainEdema

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • GÜLŞAH BARĞI, Assoc. Dr.

    Izmir Democracy University

    STUDY DIRECTOR
  • ÖZLEM ÇİNAR ÖZDEMİR, Assoc. Dr.

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • CEMRE GÖRÜNMEZOĞLU, MSc

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • DÜNDAR ÖZALP KARABAY, Prof. Dr.

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single-blind study; the patients will not be informed about training group or control group and they will be evaluated and trained at different places and times.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. prof

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 8, 2023

Study Start

September 15, 2023

Primary Completion

June 30, 2024

Study Completion

December 30, 2024

Last Updated

May 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations